Gennex Laboratories announced that the 39th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 6 September 2024.Powered by Capital Market - Live News

Net profit of Gennex Laboratories rose 63.51% to Rs 4.66 crore in the quarter ended June 2024 as against Rs 2.85 crore during the previous quarter ended June 2023. Sales rose 71.74% to Rs 28.32 crore in the quarter ended June 2024 as against Rs 16.49 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales28.3216.49 72 OPM %23.6230.93 - PBDT5.964.37 36 PBT5.513.72 48 NP4.662.85 64 Powered by Capital Market - Live News

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live News

Net profit of Gennex Laboratories rose 120.59% to Rs 4.50 crore in the quarter ended March 2024 as against Rs 2.04 crore during the previous quarter ended March 2023. Sales rose 79.53% to Rs 33.50 crore in the quarter ended March 2024 as against Rs 18.66 crore during the previous quarter ended March 2023.For the full year,net profit rose 167.89% to Rs 13.18 crore in the year ended March 2024 as against Rs 4.92 crore during the previous year ended March 2023. Sales rose 32.18% to Rs 86.71 crore in the year ended March 2024 as against Rs 65.60 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales33.5018.66 80 86.7165.60 32 OPM %18.7218.86 -25.3013.19 - PBDT5.532.89 91 18.867.29 159 PBT5.302.52 110 16.496.37 159 NP4.502.04 121 13.184.92 168 Powered by Capital Market - Live News